Revvity, Inc., formerly known as PerkinElmer, Inc., is a renowned company specializing in the development and marketing of measuring devices and analytical instruments.
Their expertise spans across various sectors, including healthcare, environmental, scientific research, industrial, and food industries.
The company's net sales primarily come from medical diagnostic devices, accounting for 61% of total sales, while analytical devices and instruments contribute 39%.
In terms of geographical distribution, the majority of Revvity's sales are generated in the United States, representing 46.7% of total net sales. China follows with 14.4%, and the United Kingdom accounts for 4.1%. The remaining 34.8% of sales come from other international markets, showcasing the company's global presence.
UBS has maintained a neutral stance on Revvity, reflecting a cautious outlook on the company's performance in the current market environment.